Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis
1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural ...
Tag: Johnson & Johnson
Johnson & Johnson and Legend Biotech’s Carvykti shows improved survival in treatment-experienced multiple myeloma patients
As a 2nd line therapy for multiple myeloma, Carvykti can lower the risk of disease progression or death by 59% ...
Single-dose Ad26.COV2.S reduces risk of COVID-related hospitalization and death in South African healthcare workers
1. Single-dose of Ad26.COV2.S reduces risk of COVID-related hospitalization by 67% compared to matched unvaccinated control group. 2. Breakthrough infections ...
#VisualAbstract: COVID-19 vaccines provided durable protection from COVID-19, but their effectiveness waned over time in North Carolina
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable protection against hospitalization and death. 2. However, ...
